Giles K, et al. Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM. ECTRIMS 2018, P595.
Solanezumab bij preklinische ziekte van Alzheimer: fase III-resultaten
okt 2023 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen